Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-30.92	103.89	150.38
Graham Fair Price	0.27	48.84	48.71
PEG	615.85	62.04	-8.67
Price/Book	8.15	3.46	3.20
Price/Cash Flow	-9.18	127.72	140.63
Prices/Earnings	7.17	42.50	39.65
Price/Sales	-49.79	31.91	63.55
Price/FCF	-9.18	127.72	140.63
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.17	0.60	0.60
Operating Margin	12.68	0.23	0.20
ROA	2.15	0.01	0.01
ROE	0.02	0.02	0.92
ROIC	< 0.005	0.02	77.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.11	87.79
Dividends QOQ	2.15	-0.72	-66.59
EBIT QOQ	-0.62	1.43	128.47
EPS QOQ	-0.05	< 0.005	-85.03
FCF QOQ	-0.07	0.19	175.65
Revenue QOQ	-0.61	1.15	89.46
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	218.19	103.10	-52.75
Days Sales Outstanding (DSO)	131.07	52.47	-59.97
Inventory Turnover	0.41	0.87	111.63
Debt/Capitalization	0.27	0.26	-0.97
Quick Ratio	1.18	1.34	13.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	72.30	72.16	-0.19
Cash	7.93	9.49	19.77
Capex	-0.54	-0.39	27.69
Free Cash Flow	1.65	1.96	18.85
Revenue	3.64	7.83	114.99
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.68	1.85	9.70
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.12	6.44	-42.07
Naive Interpretation	Member

06 - Financial Health · Weak

Rating